 |
|
OHSU scientists partner with others to form center aimed at combating infectious diseases
April 16, 2009The Pacific Northwest Regional Center for Excellence will bring together vaccine and infectious disease researchers from Oregon, Washington, Idaho and Alaska
PORTLAND, Ore. -- Oregon Health & Science University and the University of Washington, along with a number of partner institutions across the Northwest, have received federal funding to form a regional research center aimed at combating emerging or re-emerging infectious diseases that pose a serious threat to human health.
Based at OHSU, the collaborative Pacific Northwest Regional Center for Excellence (PNWRCE) for Biodefense and Emerging Infectious Diseases was established through a five-year, $40.7 million cooperative agreement from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health. Jay Nelson, Ph.D., is director of the PNWRCE and OHSU's Vaccine and Gene Therapy Institute (VGTI), and Michael Katze, Ph.D., UW professor of microbiology, is co-director of the PNWRCE.
"Since the anthrax attacks in 2001, the country has rapidly expanded our ability to detect and combat infectious diseases whether they are spread naturally or through a bioterrorist attack," said Dr. Nelson. "These regional research centers located across the country serve to better protect the population while at the same time conducting research aimed at preventing or successfully combating a public health crisis -- recent examples would include threats posed in the past few years by influenza, West Nile virus and SARS."
Members of the PNWRCE will work closely with public health departments in all participating Northwest states in training and research. The members will also collaborate with newly funded science initiatives within the state such as the Oregon Translational Research and Drug Development Institute. OTRADI provides crucial research services to Oregon researchers involved in pharmaceutical development and will be an important partner in the research.
PNWRCE researchers will study a broad range of diseases and viruses, including Ebola, Dengue, SARS, avian and 1918 influenza, dengue fever, yellow fever, and West Nile, all of which are caused by pathogens that NIAID categorizes as A, B and C. NIAID priority pathogens in category A are the most dangerous and include Ebola and Dengue.
The PNWRCE will focus on two main areas to identify potential therapeutic targets for infectious disease: 1) research investigating defects in the immune system caused by aging, and 2) the study of disease-host interactions through newly advanced techniques in genomics and genetic analyses. Both research areas will facilitate the development of vaccines and other therapies.
Janko Nikolich-Zugich, M.D., Ph.D., an expert in the immunology of the aged, will lead theme one of the PNWRCE project, "Identifying Immune Defects in the Aged Immune Systems." Mark Slifka, Ph.D., associate scientist, OHSU VGTI, will investigate "Yellow Fever Vaccination of the Elderly and Immune Compromised".
"The increasing incident of newly emerging disease requires novel approaches in the development of new therapeutics," Katze said. "Our program at the University of Washington in genomic technologies will dovetail nicely with the research proposed in the PNWRCE. We look forward to this unique collaborative effort between our two universities."
Katze will use systems-level approaches to define potential therapeutic targets in pathogenesis and immunity, one of two major PNWRCE projects that will take place at the UW. Michael Gale Jr., UW associate professor of immunology, is the principal investigator of a second project, "Pro- and Anti-Viral Host Pathways in Flavivirus Pathogenesis." Both the Washington National Primate Research Center at UW and the Oregon National Primate Research Center at OHSU will play prominent roles in the new center.
The 11 federally funded centers for excellence exist in 10 different multi-state regions of the country - regions defined by the National Institutes of Health. The northwest region (region 10) includes Alaska, Idaho, Oregon and Washington. Two regional centers exist in region 10: the new PNWRCE based at OHSU and another previously founded center based at the University of Washington. Region 10 is the only region in the country that is home to two regional centers.
"We are delighted to participate in this NIAID program," said Dan Dorsa, Ph.D., OHSU vice president for research. "The Northwest has some of the best immunology, virology and bacterial experts in the world, and the formation of this center provides an extraordinary opportunity to combine the expertise of these individuals in the fight against infectious disease. We also feel that this partnership with the University of Washington will provide the seed for future opportunities between our two institutions."
Oregon Health & Science University
"Since the anthrax attacks in 2001, the country has rapidly expanded our ability to detect and combat infectious diseases whether they are spread naturally or through a bioterrorist attack," said Dr. Nelson. "These regional research centers located across the country serve to better protect the population while at the same time conducting research aimed at preventing or successfully combating a public health crisis -- recent examples would include threats posed in the past few years by influenza, West Nile virus and SARS."
Members of the PNWRCE will work closely with public health departments in all participating Northwest states in training and research. The members will also collaborate with newly funded science initiatives within the state such as the Oregon Translational Research and Drug Development Institute. OTRADI provides crucial research services to Oregon researchers involved in pharmaceutical development and will be an important partner in the research.
PNWRCE researchers will study a broad range of diseases and viruses, including Ebola, Dengue, SARS, avian and 1918 influenza, dengue fever, yellow fever, and West Nile, all of which are caused by pathogens that NIAID categorizes as A, B and C. NIAID priority pathogens in category A are the most dangerous and include Ebola and Dengue.
The PNWRCE will focus on two main areas to identify potential therapeutic targets for infectious disease: 1) research investigating defects in the immune system caused by aging, and 2) the study of disease-host interactions through newly advanced techniques in genomics and genetic analyses. Both research areas will facilitate the development of vaccines and other therapies.
Janko Nikolich-Zugich, M.D., Ph.D., an expert in the immunology of the aged, will lead theme one of the PNWRCE project, "Identifying Immune Defects in the Aged Immune Systems." Mark Slifka, Ph.D., associate scientist, OHSU VGTI, will investigate "Yellow Fever Vaccination of the Elderly and Immune Compromised".
"The increasing incident of newly emerging disease requires novel approaches in the development of new therapeutics," Katze said. "Our program at the University of Washington in genomic technologies will dovetail nicely with the research proposed in the PNWRCE. We look forward to this unique collaborative effort between our two universities."
Katze will use systems-level approaches to define potential therapeutic targets in pathogenesis and immunity, one of two major PNWRCE projects that will take place at the UW. Michael Gale Jr., UW associate professor of immunology, is the principal investigator of a second project, "Pro- and Anti-Viral Host Pathways in Flavivirus Pathogenesis." Both the Washington National Primate Research Center at UW and the Oregon National Primate Research Center at OHSU will play prominent roles in the new center.
The 11 federally funded centers for excellence exist in 10 different multi-state regions of the country - regions defined by the National Institutes of Health. The northwest region (region 10) includes Alaska, Idaho, Oregon and Washington. Two regional centers exist in region 10: the new PNWRCE based at OHSU and another previously founded center based at the University of Washington. Region 10 is the only region in the country that is home to two regional centers.
"We are delighted to participate in this NIAID program," said Dan Dorsa, Ph.D., OHSU vice president for research. "The Northwest has some of the best immunology, virology and bacterial experts in the world, and the formation of this center provides an extraordinary opportunity to combine the expertise of these individuals in the fight against infectious disease. We also feel that this partnership with the University of Washington will provide the seed for future opportunities between our two institutions."
Oregon Health & Science University
Infectious Diseases Current Events and Infectious Diseases News RSSWhen should flu trigger a school shutdown?
As flu season approaches, parents around the country are starting to face school closures. But how bad should an influenza outbreak be for a school to shut down?
PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines
Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa.
Poorly cleaned public cruise ship restrooms may predict norovirus outbreaks
team of researchers from Boston University School (BUSM), Carney Hospital, Cambridge Health Alliance and Tufts University School of Medicine, have found that widespread poor compliance with regular cleaning of public restrooms on cruise ships may predict subsequent norovirus infection outbreaks (NoVOs).
Initial Results Show Pregnant Women Mount Strong Immune Response To One Dose of 2009 H1N1 Flu Vaccine
Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.
Flu vaccine given to women during pregnancy keeps infants out of the hospital
Infants born to women who received influenza vaccine during pregnancy were hospitalized at a lower rate than infants born to unvaccinated mothers.
Global challenges and opportunities in fighting HIV/AIDS and neglected diseases
Responding to the HIV/AIDS pandemic and tackling so-called neglected tropical diseases are the focus of the November/December 2009 edition of Health Affairs.
Progress made on group B streptococcus vaccine
Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible.
Pandemic flu vaccine campaigns may be undermined by coincidental medical events
The effectiveness of pandemic flu vaccination campaigns - like that now underway for H1N1 - could be undermined by the public incorrectly associating coincidental and unrelated health events with the vaccines.
USU scientists report major advance in human antibody therapy against deadly Nipah virus
A collaborative research team from the Uniformed Services University of the Health Sciences (USU), Australian Animal Health Laboratory and National Cancer Institute, a component of the National Institutes of Health, reports a major step forward in the development of an effective therapy against two deadly viruses, Nipah virus and the related Hendra virus.
Media availability: The role of biomedical research in malaria eradication
Although malaria has been controlled in many local and regional populations, the permanent elimination of malaria parasites throughout the world remains an elusive goal, and the disease continues to claim nearly one million lives each year.
More Infectious Diseases Current Events and Infectious Diseases News Articles
 |
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases: Expert Consult Premium Edition - Enhanced Online Features and Print by Gerald L. Mandell (Author) After thirty years, PPID is still the reference of choice for comprehensive, global guidance on diagnosing and treating the most challenging infectious diseases. Drs. Mandell, Bennett, and Dolin have substantially revised and meticulously updated, this new edition to save you time and to ensure you have the latest clinical and scientific knowledge at your fingertips. With new chapters, expanded and updated coverage, increased worldwide perspectives, and many new contributors, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th Edition helps you identify and treat whatever infectious disease you see. And, as an Expert Consult title with enhanced online features, this updated 7th edition comes with convenient access to the full text online, regular... |
 |
Infectious Diseases: A Clinical Short Course, Second Edition (LANGE Clinical Medicine) by Frederick Southwick (Author) Gain a full understanding of clinical infectious diseases in just thirty days A Doody's Core Title! No other resource makes clinical infectious diseases more manageable and easy to master than Infectious Diseases: A Clinical Short Course. This one-of-a-kind self-instruction tool is organized by system/region as opposed to pathogens -- simulating how common pathogens and disorders would be encountered in rounds or in practice. For this reason, this remarkable resource is unsurpassed for learning how to associate pathogens with their corresponding impact on actual patients. Features: A true, concise “short course” format that can be read and understood in the span of a 30-day infectious disease rotation Numerous case examples... |
 |
Clinical Infectious Disease by David Schlossberg (Editor) This clinically-oriented, user-friendly text is the best on the market for infectious disease. Complete and comprehensive, Schlossberg's text will be an effective reference for any practitioner who may encounter these afflictions. The orientation of the volume is multi-faceted: in addition to the traditional organization of organ system and pathogen-related information, this text includes specific sections on the susceptible host, travel-related infections, nosocomial infections, infections related to trauma, and bioterrorism. The information on post-surgical infections will be of great interest to practicing surgeons. Informative algorithms, tables, and high-quality color photographs supplement many of the chapters in this conveniently-sized volume. For practicality and ease of use, one... |
 |
Infectious Diseases, Second Edition (EXPERT GUIDE SERIES- AMERICAN COLLEGE OF PHYSICIANS) by James S. Tan (Editor), Michael J. Tan (Editor), Robert A. Salata (Editor), Thomas M. File Jr. (Editor) Here s the expert guidance practitioners need to diagnose and treat the most commonly encountered infections! This fully revised and updated New Edition keeps readers current with the latest etiologic agents, the most appropriate diagnostic tests, and the most effective management options. The 2nd Edition features new chapters on Antimicrobial Agents for the Primary Care Physician and Prosthetic Joint Infections. FEATURES: -Examines infections of the central nervous system, heart and blood vessels, gastrointestinal tract, genitourinary system, respiratory tract, skeletal system, and the skin. -Features individual chapters on HIV, herpes virus, Lyme disease, and malaria. -Puts key information at the reader s fingertips with diagnostic and treatment tables throughout the text. -Reviews... |
 |
Infectious Disease: A Scientific American Reader (Scientific American Readers) by Scientific American (Editor) The international public health scare that resulted last year when a man infected with multidrug-resistant tuberculosis flew overseas from the United States and back illustrates both the fear and the potential impact of highly infectious diseases in a global age. At a time when scientists warn of the potential for an influenza epidemic to rival the deadly outbreak of 1919 and newspapers feature alarming headlines about incidences of mad cow disease, infectious disease will be a critical area of concern and scientific study in the twenty-first century. Infectious Disease collects thirty of the most exciting, innovative, and significant articles on communicable illness published in the pages of Scientific American magazine since 1993. With sections devoted to viral infections,... |
 |
Infectious Disease Epidemiology: Theory And Practice by Kenrad E., M.D. Nelson (Author), Carolyn F. Masters, Ph.D. Williams (Author) This thorough revision contains new chapters on principles of immunology, measles and polio, meningococcal infections, including pneumococcal, and influenza infections. The chapter on emerging infections has been divided into one of mosquito borne infections and includes West Nile Virus, Rift V and Dengue as well as other arthropod borne infections. SARS and Monkey Poxare included in the new chapter. All other chapters have been updated. |
 |
Infectious Diseases (Infectious Diseases ( Gorbach )) by Sherwood L Gorbach (Editor), John G Bartlett (Editor), Neil R Blacklow (Editor) Tufts Univ. School of Medicine, Boston, MA. Provides comprehensive guidelines on the diagnosis, treatment, and prevention of every infectious disease seen in current clinical practice. Discusses new information on hospital infections, bioterrorism, toxic shock syndrome, West NIle virus, hepatitis, and more. Previous edition: c1998. DNLM: Communicable Diseases. |
 |
The A to Z of Infectious Diseases (Concise Encyclopedia) by Carol Turkington (Author), Bonnie Lee, M.d. Ashby (Author) In the past 25 years, more than 30 new germs affecting humans have emerged onto the medical scene, most of them rising from animals. New diseases like the avian flu, Ebola, SARS, and weaponized viruses such as anthrax and smallpox pose a growing danger to the world. With the threat of infectious diseases remaining constant, it is essential to have clear and concise information on this topic. "The A to Z of Infectious Diseases" provides more than 600 up-to-date entries covering the latest research, new treatments and vaccines, and rising diseases such as mad cow disease. Appendixes include drugs used to treat infectious diseases, tips for home disinfection, and lists of helpful organizations and publications, making this the ultimate resource for knowledge about infectious diseases. Topics... |
 |
Current Diagnosis & Treatment In Infectious Diseases (Current Diagnosis and Treatment in Infectious Diseases) by Walter R. Wilson (Author) Numerous quick-access boxes and tables summarize key information on one of the leading causes of death. This title covers the essentials of diagnosis, syndromes in children and adults, and treatments, including first and second-choice options. It blends practice-oriented, authoritative coverage with just the right amount of microbiology for understanding diagnostic and management decisions. |
 |
Infectious Diseases: Atlas, Cases, Text by Robin Cooke (Author) We are pleased to announce the WINNER of the Australian Publishers Association – The Australian educational publishing awards 2009 Tertiary (Wholly Australian) Scholarly Reference INFECTIOUS DISEASES: ATLAS, CASES, TEXT
“The book makes a major contribution to the study of infectious diseases both nationally and internationally. The high calibre of the research informing the content is matched by the illustrations and photos. This is a reference of significance in a vibrant and ever changing field of research and scholarship.”
Infectious diseases are the world's leading cause of premature death. Infectious Diseases; Atlas, Cases, Text presents 1500 high quality colourful images of clinical features resulting from infections, as... |
| © 2009 BrightSurf.com |